Results 241 to 250 of about 434,626 (386)

Machine Learning‐Based Prediction of Life‐Threatening Complications During Hemodialysis in Hospitalized Patients With Poor General Conditions

Artificial Organs, EarlyView.
A machine learning model using predialysis data predicted sudden events during or after hemodialysis with high accuracy (auROC: 0.889). The key predictors included emergency hospitalization, recent surgery, high heart rate, low albumin levels, and high CRP.
Naotaka Kato, Takeshi Goto, Tomoyuki Ohira, Hirotaka Kinoshita, Kugo Kurokawa, Kouhei Naganuma, Chikako Ohminato, Junko Ogasawara, Shingo Hatakeyama, Yoshihiro Sasaki, Kazuyoshi Hirota, Chikara Ohyama   +11 more
wiley   +1 more source

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program. [PDF]

Open Forum Infect Dis
Hlynsdottir K, Olafsson S, Hernandez UB, Kristjansson M, Gottfredsson M.   +4 more
europepmc   +1 more source

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

New England Journal of Medicine, 2014
J. Feld, K. Kowdley, E. Coakley, S. Sigal, D. Nelson, D. Crawford, O. Weiland, H. Aguilar, J. Xiong, T. Pilot‐Matias, Barbara DaSilva-Tillmann, L. Larsen, T. Podsadecki, B. Bernstein   +13 more
semanticscholar   +1 more source

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
Extracellular matrix (ECM) remodelling biomarkers reflect portal hypertension and disease severity in advanced chronic liver disease (ACLD). However, their predictive value for disease progression is largely restricted to compensated ACLD (cACLD). ABSTRACT Background Extracellular matrix (ECM) remodelling in advanced chronic liver disease (ACLD) is ...
Benedikt Simbrunner, Ida Falk Villesen, Georg Semmler, Lorenz Balcar, Georg Kramer, Joana Almeida Calvão, Benedikt Silvester Hofer, Mathias Jachs, Lukas Hartl, Jurij Maurer, Bernhard Scheiner, Kerstin Zinober, Rodrig Marculescu, Michael Trauner, Morten Karsdal, Thomas Reiberger, Mattias Mandorfer, Diana Julie Leeming   +17 more
wiley   +1 more source

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

New England Journal of Medicine, 2014
S. Zeuzem, G. Dusheiko, R. Salupere, A. Mangia, R. Flisiak, R. Hyland, A. Illeperuma, E. Svarovskaia, D. Brainard, W. Symonds, G. Subramanian, J. Mchutchison, O. Weiland, H. Reesink, P. Ferenci, C. Hézode, R. Esteban   +16 more
semanticscholar   +1 more source

HCV Polymerase Inhibitors [PDF]

ACS Medicinal Chemistry Letters, 2013
openaire   +2 more sources

Very Early‐Stage Detection Is Associated With Improved Survival in Patients With Unifocal Hepatocellular Carcinoma

Alimentary Pharmacology &Therapeutics, EarlyView.
In a multicentre cohort of patients with unifocal HCC, patients with very early stage disease had a survival advantage over patients diagnosed at an early stage. Factors associated with mortality included worse liver function, larger tumour size and higher AFP levels.
Thomas Hunold, Karim Seif El Dahan, Suraj Pai, Amit G. Singal, Neehar D. Parikh   +4 more
wiley   +1 more source

Hepatitis B Virus RNA Predicts Hepatocellular Carcinoma Despite Viral Suppression

Alimentary Pharmacology &Therapeutics, EarlyView.
Serum HBV RNA levels at viral suppression predict HCC development in nucleos(t)ide analogue‐treated patients with chronic hepatitis B, outperforming Hepatitis B core‐related antigen alone. ABSTRACT Background Despite achieving undetectable hepatitis B virus (HBV) DNA levels with nucleos(t)ide analogue (NA) therapy, patients with chronic hepatitis B ...
Takashi Kumada, Hidenori Toyoda, Satoshi Yasuda, Yuichi Koshiyama, Takanori Ito, Tomoyuki Akita, Junko Tanaka   +6 more
wiley   +1 more source

Prevalence of Hepatitis C Virus Antibody Testing Across Geography, Time, and Social Vulnerability Among Adults in Florida, 2015-2021. [PDF]

Public Health Rep
Christy SM, Buhlmann M, Kang D, Reich RR, Rathwell JA, Kasting ML, Vadaparampil ST, Giuliano AR.   +7 more
europepmc   +1 more source

The interaction between HCV and nuclear receptor-mediated pathways

, 2011
Zoe Raglow, Carly Thoma-Perry, Richard Gilroy, Yu‐Jui Yvonne Wan   +3 more
openalex   +2 more sources